On September 3, John Wiley & Sons (NYSE:WLY) opened its fiscal 2027 with a headline that looked worse than the business underneath it. Revenue fell 3% to $386 million, and adjusted earnings per share dropped 10% to $0.44 from $0.49. But most of that decline traces back to a single, known comparison problem, and the parts of Wiley actually built for the future kept moving in the right direction.
A Flywheel Finally Turning
Wiley’s research business, its publishing engine, brought in $293 million in revenue, up 4%, with research publishing itself climbing 12% to $259 million. Submissions rose 31% year over year and output grew 8%, evidence that demand to publish keeps outpacing even an already strong market. Journal customer retention held above 99% through the 2026 renewal season, a signal that the core subscription base isn’t eroding even as the company reshapes itself around data and AI.
The AI business is still small in dollar terms, $14 million this quarter, but the mix is shifting the way management wants. Of that figure, $10.5 million came from model training, $3.5 million was recurring, and another $14 million is already contracted for delivery across the next two quarters. Wiley was invited as the only scientific publisher into the US Department of Energy’s Genesis Mission and became a founding data partner in Cusp AI’s Global Materials Foundry, both wins that suggest its content library is becoming infrastructure rather than just archive material.
The company also launched a spectral analysis API portfolio aimed at corporate and academic labs, extending its reach into automated research pipelines. Clinical outcome assessments revenue, the peer-reviewed instruments used in clinical trials, rose more than threefold. Layer on the Emerald Publishing acquisition, which added $13 million in revenue and $5 million in adjusted EBITDA and which management says is integrating ahead of schedule, and the research and AI engines both look like they’re compounding rather than stalling.
Where The Cracks Show
The learning segment is the clear soft spot, with revenue down 20% to $93 million. Academic revenue fell 20% to $45 million and professional revenue fell the same amount to $48 million, hurt by softer consumer demand in retail and weaker corporate demand for assessments. Part of that decline is simply the loss of a $29 million non-recurring AI licensing benefit that landed in last year’s quarter, but even stripping that out, learning still shrank by close to 10%.
The Emerald deal, while strategically sound so far, also added financial weight. Net debt reached $1.2 billion, pushing net debt to EBITDA to 2.7 times, up from 1.9 times a year earlier, and higher interest expense tied to the acquisition was one of the drags on adjusted EPS. Free cash flow remained negative for the quarter, a $70 million use of cash, though that was an improvement from the $100 million use a year ago. None of this derails the balance sheet, but it does mean the company is carrying more leverage while it works on integration and cost synergies.
A Cautious Crowd Watching Closely
Hedge fund ownership slipped from 21 funds to 16 in the most recent quarter, a pullback that suggests institutional conviction cooled somewhat heading into this report. Short interest sits at 15.28% of float, a level that points to a meaningful bear camp already positioned against the stock rather than passive skepticism. That combination points to a market still unconvinced the AI and research growth story outweighs the leverage and the learning segment’s struggles.
What Happens From Here
Wiley reaffirmed its full-year guidance, including adjusted EPS of $4.60 to $5.05, up from $4.19, and organic revenue growth in the low to mid single digits. The tension is straightforward. Research and AI licensing are producing real, measurable growth, and partnerships like the Genesis Mission add credibility that’s hard to fake. But learning’s slide and the higher debt load from Emerald are real costs of the transition.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
